Newsroom | 9970 results

CHICAGO--(BUSINESS WIRE)--Emalex Biosciences received a patent covering an orally disintegrating tablet (ODT) formulation of ecopipam, an investigational D1 antagonist...

CHICAGO--(BUSINESS WIRE)--New independent study from the Integrated Benefits Institute shows ComPsych behavioral health services deliver 507% ROI....

JANESVILLE, Wis.--(BUSINESS WIRE)--Blain's Farm & Fleet Earns Spot on Newsweek’s Greatest Workplaces for Mental Well-Being 2026 List...

SAN FRANCISCO & BUFFALO, N.Y.--(BUSINESS WIRE)--Osmind, the platform powering the largest network of independent psychiatry practices, and CareNet GPO, a group purchasing organization focused on psychiatry and behavioral health, today announced an exclusive partnership that gives independent practices the purchasing power and operational support to offer innovative psychiatric treatments sustainably—reducing drug costs and simplifying the workflows required to deliver them. The partnership conn...

NEW YORK--(BUSINESS WIRE)--Dreem Health, a leading virtual sleep clinic managed by Sunrise Group, has become the first sleep care service to join Amazon’s Health Benefits Connector. Amazon customers eligible for insurance-covered sleep services can discover and enroll in Dreem Health’s personalized care when browsing for healthcare services. More than 70 million Americans live with sleep disorders, yet there is only one sleep doctor for every 43,000 people. This shortage leaves millions waiting...

HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, announces the publication of a research study led by Dr. David Beers and Dr. Stanley Appel at the Houston Methodist Neurological Institute. The study included the longitudinal measurement of well-characterized serum biomarkers of lipid peroxidation (4-hydroxy-2-nonenal [4-HNE]), systemic inflammation (lipopolys...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company’s management team will participate in the following investor conferences and events: 25th Annual Needham Virtual Healthcare Conference Fireside Chat Date and Time: Thursday, April 16, 2026 at 3:00 PM EDT Webcast...

HONG KONG--(BUSINESS WIRE)--MetLife Foundation announced new recipients of its Community Impact Grant Program (CIGP), providing more than $6.5 million to global nonprofit organizations, including 26 in Asia, addressing essential community needs. By tackling critical issues, the program supports non-profits providing the services and resources people reply on to build financial security and resilience, reflecting MetLife and MetLife Foundation’s long‑standing commitment to helping people and com...

EL PASO, Texas--(BUSINESS WIRE)--Jordan Foster Construction was honored by the Associated Builders and Contractors with the 2025 National Health and Safety Excellence Award....

NEW YORK--(BUSINESS WIRE)--ReflexAI is expanding its collaboration with Google.org to address the global challenge of training within social sector organizations....